YD Bio income statement data for the quarter ended Jun 2026. This income statement covers 4 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2024 | Jun2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|
| Additional items | ||||
| Shares Outstanding | 64.73M | 64.73M | 66.72M | 66.72M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 64.73M | 64.73M | 66.72M | 66.72M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 64.73M | 70.79M |